Does Prednisone Help With Upper Respiratory Infection?

For the most common type of upper respiratory infection, the ordinary cold, prednisone has not been shown to reduce symptoms or shorten the illness. A Cochrane review of placebo-controlled trials found no benefit from corticosteroids in either symptom duration or severity for the common cold.¹ But “upper respiratory infection” is an umbrella that covers sore throats, sinus infections, and croup in children, and the picture shifts depending on which one you’re dealing with.

Why the Answer Depends on Which URI You Have

Doctors and patients alike tend to lump together everything that happens above the lungs and call it an upper respiratory infection. In practice, though, the term spans at least four distinct conditions: the common cold (viral rhinitis), sore throat (pharyngitis), acute sinus infections (rhinosinusitis), and croup in young children. Each involves different anatomy, different degrees of inflammation, and different immune responses. That matters because prednisone’s main trick is tamping down inflammation. When inflammation is the primary driver of your misery, a steroid can help. When a virus is simply running its course and inflammation is only a minor player, the drug doesn’t have much to work with.

The Common Cold

This is where the evidence is most clear-cut and most disappointing for anyone hoping prednisone would speed things up. The Cochrane review looked at placebo-controlled trials of intranasal corticosteroids for the common cold. In one trial of 54 people, the average number of symptomatic days was about 10 in both the steroid and placebo groups. A second trial of roughly 200 participants likewise found no meaningful differences.¹ The cold virus causes relatively modest airway inflammation in most people, and the body clears it on a timeline that steroids don’t seem to budge.

One nuance worth noting: these trials studied nasal steroid sprays rather than oral prednisone. But if a locally concentrated steroid applied directly to the affected tissue does nothing, there’s little reason to expect an oral steroid, which affects the whole body and carries more side effects, to fare better. No major guideline recommends oral corticosteroids for an uncomplicated cold.

Sore Throat Is the Exception

If you’ve had a doctor prescribe a short burst of steroids for a bad sore throat, there’s actually decent evidence behind that decision. A systematic review and meta-analysis of randomized trials published in the BMJ found that a single low dose of a corticosteroid (most commonly dexamethasone, up to 10 mg) roughly doubled the chances of experiencing pain relief within 24 hours compared to placebo. At 48 hours, steroid-treated patients were about one and a half times more likely to be pain-free. On average, the onset of pain relief came nearly five hours sooner, and complete resolution of pain arrived roughly 11 hours earlier.²

A separate randomized trial looking specifically at short-acting oral prednisone in pharyngitis found similar results: patients on the steroid experienced faster resolution of throat pain than the placebo group, with no reported adverse effects and no difference in symptom recurrence or bacterial culture outcomes.³

The reason steroids work better here than for a cold is straightforward. A severely sore throat involves intense localized inflammation of the pharyngeal tissue, swelling that makes swallowing painful and sometimes difficult. That’s exactly the kind of problem a potent anti-inflammatory can address. The steroid doesn’t kill the virus or bacterium causing the infection; it just dials down the inflammatory response that’s producing most of the suffering. Importantly, these benefits came from short, low-dose courses, not prolonged steroid therapy.

Acute Sinus Infections

Acute sinusitis sits somewhere between the cold and the sore throat in terms of steroid responsiveness. A Cochrane review combining data from five trials found that oral corticosteroids modestly increased the likelihood of symptom resolution or improvement. In the short term (three to seven days), about 17% more patients in the steroid group improved compared to controls. Over a slightly longer window of four to 14 days, the advantage was around 14%.⁴

Those numbers are real but modest. In practical terms, if you lined up 100 people with acute sinusitis and gave half of them a steroid alongside standard care, roughly 17 extra people in the steroid group would feel better within a week compared to the group that skipped it. That’s not nothing, especially if you’re the one with a pounding sinus headache, but it also means the majority of people improve at about the same pace regardless. Clinicians sometimes prescribe a short oral steroid course as an add-on when sinusitis is particularly severe or when nasal congestion is extreme, but it’s generally not a first-line standalone treatment.

Croup in Children

Croup is one respiratory condition where corticosteroids have a well-established role, though prednisone isn’t the preferred option. Dexamethasone, a longer-acting steroid, has become the standard because it can be given as a single dose and keeps working for longer. A head-to-head randomized trial found that children treated with a single dose of prednisolone were considerably more likely to need unscheduled follow-up medical care: roughly 29% came back, compared to about 7% of those who received dexamethasone.⁵

A larger follow-up trial somewhat narrowed that gap. It found that dexamethasone, low-dose dexamethasone, and prednisolone all produced similar croup symptom scores at one hour, with re-attendance rates that were not statistically different across groups (roughly 18% to 22%).⁶ And a study of children hospitalized for more severe croup found no significant differences in hospital resource use between dexamethasone and prednisone/prednisolone, concluding both were reasonable options in that setting.⁷

The practical takeaway for parents: steroids clearly help with croup, reducing airway swelling that causes the characteristic barking cough. But if your pediatrician reaches for dexamethasone instead of prednisone, that’s not arbitrary. Dexamethasone’s longer duration of action means fewer doses, better convenience, and potentially fewer return visits. Most pediatric guidelines have settled on dexamethasone as the go-to.

A related finding from a review of pediatric respiratory conditions is that systemic steroids have no demonstrated benefit for acute bronchiolitis in young children and that their use in that condition should be discouraged. The same review noted that most available studies have not shown benefit for steroid use during acute wheezing episodes in preschool-aged children.⁸ So even in pediatrics, the steroid benefit is narrower than many parents assume.

What About Lower Respiratory Infections?

Although the title question asks about upper respiratory infections, many people who get prescribed prednisone for a “chest cold” or a lingering cough wonder whether it’s doing anything. The largest trial addressing this enrolled about 400 adults with acute lower respiratory tract infections (think acute bronchitis) who did not have asthma. Participants received either prednisolone at 40 mg per day for five days or a placebo. The median cough duration was five days in both groups. Symptom severity scores were almost identical, and there were no meaningful differences in antibiotic use, peak flow recovery, or side effects.⁹

This result is worth emphasizing because acute bronchitis is one of the most common reasons doctors prescribe a short steroid burst. The JAMA trial specifically excluded people with asthma and COPD, who are a different story entirely, since steroids are well established for managing those conditions. For otherwise healthy adults with a nasty bronchitis cough, the evidence says prednisone doesn’t speed recovery.

Why Do Doctors Prescribe It So Often Anyway?

Despite the mixed evidence, steroid prescribing for respiratory infections is surprisingly common. A large U.S. population-based study found that about 12% of outpatient visits for acute respiratory tract infections resulted in a prescription for systemic steroids. Nearly half of those prescriptions were for oral steroids (mostly prednisone), with most courses lasting seven days or fewer.¹⁰

Several factors drive this. Emergency departments and urgent care settings were more likely to prescribe steroids than regular offices, as were ear-nose-and-throat specialists compared to primary care doctors.¹⁰ Part of the explanation is clinical pressure: patients who are miserable and in the exam room want relief now, and doctors feel compelled to offer something tangible. A steroid prescription signals action even when the evidence doesn’t support it. Steroids also have a powerful subjective effect in many people, a burst of energy, temporary mood elevation, and a reduction in that vague achiness. Those effects can make patients feel like the drug “worked,” reinforcing the belief for next time. But feeling better temporarily due to a systemic anti-inflammatory drug is not the same as recovering faster from an infection.

The Risks You Take for a Drug That May Not Help

This is where the cost-benefit math becomes lopsided. Even a short course of oral corticosteroids carries real risks. A large population-based study tracked adults who took short steroid bursts (typically under 30 days) and found elevated rates of three serious adverse events within the first month of use. The rate of sepsis was about five times higher, venous blood clots about three times higher, and bone fractures nearly twice as high compared to the period without steroid use. Those increased risks were not limited to high-dose prescriptions; they persisted even at doses below 20 mg per day of prednisone equivalent.¹¹

To put this in perspective, the absolute risk for any individual short course is still low. Most people who take a five-day prednisone pack for a sinus infection will not develop a blood clot. But when millions of these prescriptions are written each year for conditions where the drug provides little or no benefit, those small absolute risks translate into a meaningful number of avoidable complications at the population level. The risk equation makes sense for someone with severe asthma having an exacerbation, where the steroid can be life-saving. It makes much less sense for someone with a regular cold or a self-limiting bout of bronchitis.

Beyond those headline risks, short courses of prednisone commonly cause insomnia, mood swings, increased appetite, and elevated blood sugar. If you’ve ever taken a steroid pack and felt wired at 3 a.m. or unusually irritable, that’s a well-known effect. For people with diabetes, even a brief course can throw blood sugar control off for days.

What the Research Still Doesn’t Know

One lingering question is whether prednisone helps with the post-infectious cough that sometimes drags on for weeks after an upper respiratory infection clears. Many people are most tempted to ask for steroids at this stage, when the initial infection is gone but the cough just won’t quit. A Swiss research group has designed a randomized placebo-controlled trial specifically to test whether a five-day course of 40 mg of oral prednisone improves cough-related quality of life at 14 days in adults with post-infectious cough triggered by an upper respiratory tract infection.¹² That trial is designed to answer the question but hasn’t yet produced published results, meaning we’re currently prescribing steroids for post-infectious cough based on clinical intuition rather than solid evidence.

Another gap involves whether certain subgroups of patients, perhaps those with mild undiagnosed airway hyperreactivity who don’t meet the formal criteria for asthma, might benefit from steroids during an upper respiratory infection even though the general population doesn’t. Doctors who prescribe steroids often suspect their patient has a “reactive airway component,” but separating that clinical instinct from placebo response in a rigorous way has proven difficult. Until trials specifically stratify for borderline airway reactivity, the honest answer is that we don’t know.

When Steroids Are Genuinely Warranted During a Respiratory Illness

If your doctor prescribes prednisone and you have one of the following conditions, the steroid is working for a reason supported by good evidence:

Asthma flare-up: A viral URI is one of the most common triggers for asthma exacerbations, and oral steroids reduce airway inflammation, prevent hospitalization, and speed recovery.
COPD exacerbation: Short steroid courses are a standard part of managing acute worsening in chronic obstructive pulmonary disease.
Severe croup: Dexamethasone is preferred, but oral steroids in general reduce the dangerous airway swelling in children.
Severe sore throat: A single low dose alongside standard care reliably shortens the duration of throat pain.

If you don’t have any of these conditions and your doctor suggests prednisone for what seems like a straightforward cold or bronchitis, it’s reasonable to ask what the steroid is expected to accomplish. A good clinician won’t be offended by the question. They may have a specific reason, perhaps they heard wheezing or suspect early sinusitis, or they may reconsider. Either way, you’re making a more informed decision about whether to accept the risks of a drug that, for most uncomplicated upper respiratory infections, the evidence says doesn’t change the outcome.